2011: Year in review
Recent articles
The year in review
The ten notable papers picked by SFARI staff describe superb contributions that span the breadth of autism research from molecules to behavior. But we recognize that ten other articles might have been selected without loss of enthusiasm or excitement.
The year in review
The ten notable papers picked by SFARI staff describe superb contributions that span the breadth of autism research from molecules to behavior. But we recognize that ten other articles might have been selected without loss of enthusiasm or excitement.
Explore more from The Transmitter
Building the future of neuroscience at HBCUs
Black In Neuro is launching a new program to help historically Black colleges and universities advance neuroscience research and education, focusing on cross-institutional collaboration, joint curriculum development and improved mentoring initiatives.
Building the future of neuroscience at HBCUs
Black In Neuro is launching a new program to help historically Black colleges and universities advance neuroscience research and education, focusing on cross-institutional collaboration, joint curriculum development and improved mentoring initiatives.
Emotion research has a communication conundrum
In 2025, the words we use to describe emotions matter, but their definitions are controversial. Here, I unpack the different positions in this space and the rationales behind them—and I invite 13 experts to chime in.
Emotion research has a communication conundrum
In 2025, the words we use to describe emotions matter, but their definitions are controversial. Here, I unpack the different positions in this space and the rationales behind them—and I invite 13 experts to chime in.
Autism-linked copy number variants always boost autism likelihood
By contrast, varied doses of the same genes decrease or increase the odds of five other conditions, with distinct biological consequences, two new preprints show.
Autism-linked copy number variants always boost autism likelihood
By contrast, varied doses of the same genes decrease or increase the odds of five other conditions, with distinct biological consequences, two new preprints show.